Redcliffe Labs appoints Sanjay Bhargava as its Director M&A & Growth

New Delhi: Redcliffe Labs, a unit of Redcliffe Lifetech in the U.S. and India, has recently announced Sanjay Bhargava as its Director M&A & Growth.

Bhargava comes with over 30 years of experience across different verticals of Healthcare such as Pharma, Diagnostics, and Hospitals. He has efficiently lead innovations and entrepreneurial assignments.

A Gold Medallist in Bachelors in Pharmacy from Nagpur University, he also holds a Certification in Finance from IIM Bangalore.

Bhargava started his career as a Medical Representative with Crosslands and Cadila, before he moved into diagnostics and was instrumental in establishing & scaling up companies like Pathnet, Wellspring (Piramal Diagnostics), launching and Heading the M&A and HLM vertical for Dr. Lal Path Labs, before opening his own entrepreneurial venture HealthSquare. After which he worked at Moolchand Healthcare, International Oncology Pvt Ltd, Mirable Diagnostics (Human Health) Bengaluru , NGIVD, and Gian Health Care Ltd as CEO.

Welcoming him, Dheeraj Jain, the Founder of Redcliffe Labs said, “Sanjay is well-placed to take on this role, having been instrumental in driving M&A dialogue for different players in the diagnostics segment.

This appointment is also significant as the local M&A market continues to grow and evolve and with our expansion plan well laid out as we continue to experience strong growth momentum.”

“I am honoured to be associated with Redcliffe Labs at a time when diagnostics industry in India is witnessing exponential growth. I am thrilled to be a part of Redcliffe Labs’ growth story,” said the newly appointed Director M&A & Growth at Redcliffe Labs, Sanjay Bhargava.

In this new role, Bhagrava will lead inorganic and organic growth opportunities across the gamut of diagnostic services, driving consolidation strategy to scale up the business operations, building professional management growth teams, and transforming business management practices.